Treatment with a CO-releasing molecule (CORM-3) reduces joint inflammation and erosion in murine collagen-induced arthritis

Key Points

• Joint inflammation is significantly reduced with CORM-3 treatment, improving overall joint health.
• The study shows a notable decrease in joint erosion, emphasizing the compound's protective effects.
• Observational analysis of murine collagen-induced arthritis indicates beneficial outcomes from the CO-releasing molecule.
• The findings suggest that CORM-3 may become an important therapeutic intervention for arthritis management.